Regardless of the reason for disposing of a medical device or other electronic equipment, the product must be destroyed in a manner in which it can never be reused or identified as coming from your organization. In addition, the resulting materials from the destruction process be disposed of in an environmentally appropriate and regulatory compliant manner.
Its success lies in a synergy between the technological and the clinical.
Incorporating bioinformatics platforms can ease the burden of tracking, analyzing and managing the use of antibiotics.
Regenerative medicine unites doctors, scientists, engineers, and others to accelerate healing processes.
The challenge for the digital health community will be to bring the same high standards for care in the physical world to their digital interactions.
Moving too quickly in the product development process can lead to mistakes.
Part three of this series discusses the key defenses available to each element of a lawsuit against providers and labs.
The pandemic is helping realize the potential of ISO IDMP data standards in relation to adverse event reporting, electronic prescribing and medicines control in the supply chain.
Under the new regulation, medtech manufacturers can no longer defend their claims with limited clinical data; the depth, breadth and scrutiny on clinical data is much more rigorous.
To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.